Management of Arsenic Infusion Reactions in Leukemia Patients

Immediate Recognition and Initial Response

The American Society of Clinical Oncology recommends stopping the infusion immediately and assessing the patient's airway, breathing, circulation, and level of consciousness in cases of arsenic trioxide infusion reactions 1, 3
Early warning signs of infusion reactions include patients feeling odd, uncomfortable, or expressing a need to urinate or defecate, and these symptoms must be taken seriously with immediate blood pressure and pulse rate measurement 1
Maintaining IV access with normal saline for medication administration and potential fluid resuscitation is crucial 4
Positioning the patient appropriately, such as in the Trendelenburg position for hypotension or sitting upright for respiratory distress, is essential 1, 3
Administering supplemental oxygen if needed is recommended 1, 5
Calling for medical assistance immediately is vital 1, 3

For Grade 1 reactions, slowing the infusion rate to 50-60 mL/hour, administering H1/H2 antihistamines, and monitoring vital signs continuously is recommended 1, 3
For Grade 2 reactions, stopping or temporarily ceasing the infusion, administering H1/H2 antihistamines and corticosteroids, and restarting the infusion at 50% rate after symptom resolution is advised 1, 2
For Grade 3-4 reactions, permanently stopping the infusion, administering epinephrine, H1/H2 antihistamines, and corticosteroids, and avoiding rechallenge is recommended 1, 2, 3

For hypotension, placing the patient in the Trendelenburg position, administering fluid resuscitation, and using vasopressors if necessary is recommended 1, 5
For bradycardia, administering atropine is advised 1, 2
For patients on beta-blockers, administering glucagon if refractory to epinephrine is crucial 1, 2, 5

Monitoring vital signs continuously until complete resolution of symptoms and observing for at least 24 hours after severe reactions to detect biphasic reactions is essential 1, 2, 3
Documenting the reaction grade, specific symptoms, timing of onset, and all treatments administered is vital 1, 3

Never delaying epinephrine administration if anaphylaxis is suspected, and not restarting infusion at full rate after a reaction are critical pitfalls to avoid 1, 3, 5
Not discharging patients prematurely, especially those with airway involvement or requiring multiple interventions, is advised 3, 5
Corticosteroids preventing biphasic reactions but providing no acute benefit, and not attempting rechallenge in Grade 3-4 reactions, are important considerations 1, 3, 5